The new $467 million includes $400 million in royalties for the Pfizer-BioNTech vaccine from 2020 through 2023.
The German drugmaker will pay the NIH $791.5 million, while the University of Pennsylvania will get up to $467 million ...
Penn has reached an agreement to resolve a dispute over Covid-19 royalties the Philadelphia university alleged it was owed.
Stocktwits on MSN4d
BioNTech Stock In Focus After $791.5M Settlement With NIH: Retail CautiousShares of BioNTech slipped 0.83% in after-hours trading on Friday after the company said it would pay $791.5 million in a ...
Seeking Alpha on MSN7d
BioNTech inks $1B settlements with NIH and Penn to resolve COVID vaccine royalty claimsBioNTech (BNTX) stock slipped after signing $1B deals with NIH and the University of Pennsylvania to resolve COVID vaccine ...
In a regulatory filing, BioNTech (BNTX) said, “BioNTech previously disclosed that it was in discussions with the National Institutes of Health concerning royalties and other related amounts allegedly ...
BioNTech has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University ...
German pharmaceutical company BioNTech has agreed to pay a combined sum of more than $1.2 billion to resolve separate ...
BioNTech has come to a settlement with both NIH and the University of Pennsylvania, by which the German pharma firm had ...
Morgan Stanley analyst Terence Flynn notes that BioNTech (BNTX) announced last week that it had reached a settlement agreement with the National Institutes of Health and University of Pennsylvania ...
In a regulatory filing, BioNTech (BNTX) said, “BioNTech previously disclosed that it was in discussions with the University of Pennsylvania ...
Bengaluru: German biotechnology company BioNTech has reached two separate settlement agreements with the U.S. National ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback